Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2
- 31 July 1992
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 64 (1), 46-56
- https://doi.org/10.1016/0090-1229(92)90058-v
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous LeprosyScandinavian Journal of Immunology, 1990
- Severe Combined Immunodeficiency Due to a Specific Defect in the Production of Interleukin-2New England Journal of Medicine, 1990
- Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule displayJournal of Allergy and Clinical Immunology, 1989
- Clinical and immunologic analyses of 103 patients with common variable immunodeficiencyJournal of Clinical Immunology, 1989
- In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiencyClinical Immunology and Immunopathology, 1988
- T-cell activation defect in common variable immunodeficiency: Restoration by phorbol myristate acetate (PMA) or allogeneic macrophagesClinical Immunology and Immunopathology, 1987
- Modulation of Suppressor-Cell Activity by Cimetidine in Patients with Common Variable HypogammaglobulinemiaNew England Journal of Medicine, 1985
- Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cellsNature, 1984
- Interleukin 2: the molecule and its functionImmunology Today, 1984
- ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIAThe Lancet, 1974